Repeat low density lipoprotein (LDL) apheresis and blood flow determinations in the forearm and leg were performed in 10 patients (age range, 13-49 years; four male, six female) with familial hypercholesterolemia (eight homozygous, two heterozygous). To perform LDL apheresis, plasma was first separated by a polysulphone hollow fiber filter; then, LDL was selectively removed from plasma by dextran sulphate cellulose beads packed in columns. Blood flows in the forearm and leg were determined at rest and during a reactive hyperemia test (peak flow). This test was performed noninvasively by a strain-gauge plethysmograph with semicontinuous registration of arterial blood flow variables before the first apheresis and 3 weeks after the last of six procedures for apheresis. Resting arterial blood flows in the forearm and leg were slightly increased after repeat LDL apheresis (p<0.05). Peak blood flow in the leg significantly increased (+34%, p<0.01). No change in peak blood flow in the forearm was observed. Systolic blood pressures were slightly but significantly reduced (p<0.05); forearm peripheral resistances were also reduced (p<0.05). Flow response was not related to LDL receptor status. Blood and plasma viscosities were determined before and 7 days after the last apheresis. Blood viscosity was significantly reduced after LDL apheresis at shear rates of 11.25-450 sec`. Plasma viscosity did not change. (Circulation 1990;81:610-616) 
F amilial hypercholesterolemia is an inherited disorder of metabolism characterized by hypercholesterolemia that is due to a marked increase of low density lipoproteins (LDL). This type of hyperlipidemia, in the homozygous form, is refractory to the conventional lipid-lowering treatments and leads to premature development of atherosclerotic cardiovascular disease.1 Nonpharmacologic treatments that have been proposed for the management of patients with familial hypercholesterolemia include plasma exchange2 and LDL apheresis.3-7The aim of these treatments is to produce a marked and sustained cholesterol-lowering effect to retard progression or induce regression of atheromatous plaques. 8 There is evidence that blood flow to the lower limbs is enhanced by the procedure of plasma exchange. 9 The time course of this effect is unrelated to changes in plasma cholesterol; the improvement in blood flow to the lower limbs is possibly explained by the simultaneous removal of several plasma constituents leading to reduced plasma and total blood viscosity.10 Moreover, simultaneous improvement of the rheologic properties of erythrocytes has been suggested.1' For most of the studies, only short-term data are available, and little is known concerning the effects of repeat procedures. 8"12 This study evaluated whether LDL apheresis-like plasma exchange affected blood flow to the limbs. In particular, we investigated the effect of repeat aphereses on blood flow to the forearm and legs.
Patients Patients With Familial Hypercholesterolemia
Repeat LDL apheresis and blood flow determinations were performed in 10 patients (age range, 13-49 years; four male, six female) with familial hypercholesterolemia (eight homozygous, two heterozygous).
The diagnosis of familial hypercholesterolemia' was based on the following criteria: 1) elevated total serum and LDL cholesterol above 270 mg/dl (7.00 mmol/l) and 200 mg/dl (5.20 mmol/l), respectively (on a free diet, before starting any treatment), 2) presence of tendon xanthomas, and 3) evidence of vertical transmission of hypercholesterolemia. Distinctive features of the homozygous form of the disease were as follows: 1) plasma cholesterol above 600 mg/dl (15.5 mmol/1) in a nonjaundiced child (before any treatment), 2) occurrence of tendon xanthomas before 20 years of age, and 3) both parents with severe hypercholesterolemia.
In four homozygous patients, the clinical and biochemical diagnosis was also supported by skin fibroblast cultures (one receptor negative, three receptor defective). Coronary angiography was performed in eight of the 10 patients. Six patients had multiple coronary stenosis, and the other two had only early lesions. Ultrasonic duplex scanning'3 of carotid arteries demonstrated carotid lesions in four of 10 patients (two stenoses were >50%). Continuous wave Doppler demonstrated abnormal ankle blood pressures in one patient. Three of 10 patients had abnormalities in the iliac arteries according to duplex scanning. Details of the diagnostic procedures used in the vascular examination have been reported elsewhere. 13 At the time of the baseline blood flow determinations, all the patients had been without drug treatment for at least 1 month; however, they were on a fat-poor diet since the time of diagnosis.
Methods
Low Density Lipoprotein Apheresis LDL apheresis was performed according to the following procedure. Blood was obtained from the antecubital vein. Plasma was first separated by a polysulphone hollow fiber filter (Sulflux FS-05, Kanekafuchi Chemical, Osaka, Japan) with average pore size of 0.2 ,um and an effective surface area of 0.5 m'. Selective removal of LDL from plasma was achieved by dextran sulphate cellulose beads (Liposorber LA-40, Kanekafuchi Chemical, Osaka, Japan) packed in columns with a volume of 400 ml. The plasma and LDL separators and the tubing system were sterile and disposable. Blood and plasma flows were driven by two independent peristaltic pumps. The whole plasma that was separated through the filter was passed through the sorbent column with downward flow, and the eluate and the blood cell rich fraction was then infused to the patient. The total extracorporeal circulating volume was about 550 ml, including the column volume of 400 ml. The system was primed with physiologic saline and successively with Ringer's lactate solution. When the circulating extracorporeal volume (550 ml) was more than 20% of total blood volume (patients with low body weight), the columns were filled with 4% human albumin. The whole operation was per-intravenously at the beginning of the procedure and then continuously infused at the rate of 1,200 lU/hr. The apheresis was repeated six times at 2-week intervals. LDL cholesterol at the end of each apheresis was reduced by an average of 61% (range, 35-89%).
Blood Flow Determinations
Blood flows in the right forearm and leg were determined noninvasively by a strain-gauge plethysmograph (Periflow, Janssen, Beerse, Belgium). Electrocardiography-triggered venous occlusion plethysmography with semicontinuous registration of arterial blood flow variables was performed. '4"15 By use of wide tubings connected with controlled pressure reservoirs and provided with electromagnetic valves, whose openings were regulated by the electrocardiography trigger unit of the plethysmograph, venous return was interrupted during three heart cycles. Because of the very short occlusion time, resistance changes in the vascular bed of the limb segment under study were negligible. The volume increase during the venous outflow occlusion, lasting three cardiac cycles, was measured with a mercury-in-silastic gauge, with high-frequency response, connected with an amplifier and a function analyzer. The cuff inflation pressure was 50 mm Hg and 90% of this pressure level was reached within 18 msec. Inflation began 90 msec after the QRS interval in the arm cuff and 150 msec after the QRS interval in the leg cuff. This time was needed for the entry of the stroke volume at the level of the occlusion cuff around the arm or the thigh. Arterial blood flow was measured during three cardiac cycles, which were followed by two cycles free from occlusion so that semicontinuous flow measurements were performed during a period of five heart beats. Each study was performed at a temperature of 22°C after at least 20 minutes of supine rest. After 10 minutes of rhythmic venous occlusion, blood flow was stabilized so that determinations could be started. After measurements of arterial blood flow were obtained at rest, peak blood flow was determined during a reactive hyperemia test. The same cuff that had been used for the venous occlusion was inflated at a suprasystolic pressure for 3 minutes to produce a transient ischemia of the limb. Then, the arterial occlusion was released, and reactive hyperemia occurred. At this time, maximal postischemic blood flow (peak blood flow) could be determined. Automatic calculation of the arterial blood flow in the limb in milliliters per minute per deciliter was performed by a built-in computer. This procedure was validated by comparing its results with those of invasive electromagnetic flowmetry. '6 Resting arterial blood flow and peak blood flow, in the right forearm and leg, were determined on the day before the first apheresis. Then, a final measurement was obtained 3 weeks after the final apheresis.
Blood pressure was measured in the right arm by formed on line. A heparin bolus (2,000 IU) was given one observer, using a sphygmomanometer, with the diastolic pressure measured at phase V. Forearm peripheral resistances17 were calculated by the ratio of mean blood pressure (diastolic + one-third pulse pressure) to resting blood flow. Values of this ratio were expressed in peripheral resistance units (PRU).
Viscosity Methods
Blood and plasma viscosities were determined before and 7 days after the final apheresis by a Wells Brookfield microviscosimeter (cone/plate 0.80) (Stoughton, Massachusetts) at shear rates from 11.25 to 450 sec'. Blood was anticoagulated with heparin (10 IU/ml), and viscosity was determined within 1 hour at 370 C.
The hematocrit level was assessed by semiautomated Sysmex CC 180 (TOA, Japan). Plasma fibrinogen was measured by radial immunodiffusion. 18 TK, an estimate of rigidity of the red blood cells,19 was calculated from the following expression: TK= (?r04l 1)/?1r04C, where 71r is the relative apparent viscosity (i.e., the viscosity of blood divided by the viscosity of plasma), and C is the hematocrit level expressed as the volume fraction. The greater the rigidity of the red cell, the higher the TK term. The normal range in our laboratory for the TK value, at a shear rate of 225 sec-', is 0.85-1.02, and the median is 0.95.
Other Methods
Serum cholesterol and triglyceride levels were determined by enzymatic methods.20 Blood cell counts and hemoglobin levels were measured by an automatic counter (Sysmex CC 780, TOA). Serum sodium levels were determined by flame photometry. Total protein concentrations were determined by the biurete method. Immunoglobulins, C3 and C4, were measured by immunonephelometry (Behring Nephelometer, Marburg, FRG). Blood urea nitrogen levels were determined by the urease method. Serum bilirubin levels were determined by photometry.
Statistical Analysis
Baseline and final blood flow determinations were compared by paired Student's t test. The main question was whether the procedure of LDL apheresis produced a flow increase or no change in flow; therefore, a one-tailed test was performed. For the other comparisons in which there was no expectation about the direction of possible changes, a two-tailed test was used.2'
Results Table 1 shows anthropometric data and major cardiovascular risk factors in the patients under study before the start of LDL apheresis. In particular, baseline cholesterol concentrations ranged from 424 to 834 mg/dl; three male patients were actual smokers, and none was hypertensive. Table 2 shows the results of blood flow determinations in the arm and leg of patients under study, including resting arterial blood flow and peak blood flow during reactive hyperemia, before and 3 weeks after six consecutive procedures for LDL apheresis. Resting arterial blood flow in the arm and leg was slightly increased after repeat procedures for LDL apheresis (p<0.05). A significant increase in peak flow in the leg was demonstrated (+34%, p<0.01). No significant change in peak blood flow in the arm was observed.
There was no relation between LDL-receptor status and flow response to LDL apheresis in the four homozygous patients whose receptor had been studied in vitro and in the two heterozygous patients ( Table 3) . Systolic blood pressure was slightly but significantly reduced after LDL apheresis (Table 4) ; forearm peripheral resistances were also reduced (p<0.05). Subjective improvement of angina was reported by three patients during the period of treatment. Table 5 illustrates the changes in some blood measurements after the same sequence of six repeat procedures of LDL apheresis. Three weeks after the final procedure, serum cholesterol levels were still 18% lower (p<0.01) than baseline levels. Platelet count, blood urea nitrogen levels, and serum sodium levels were slightly increased (p<0.05).
At the same time, red blood cell counts and hemoglobin levels were slightly reduced compared with baseline levels (about -7% and -9%, respectively).
Two female patients with concomitant hypermenorrhea developed hypocromic anemia, which was corrected by iron supplementation. Six of the 10 patients continued LDL apheresis for another 18 months; however, no further decrease in hemoglobin levels occurred. There was no correlation between the changes in serum cholesterol and hemoglobin levels and changes in blood flow in the limbs. Some reduction of C4 was also observed (p<0.05). No subjective adverse effect was reported by the patients during the period of treatment. The effect of one LDL apheresis on blood and plasma viscosity in the 10 patients was determined on the day before and 7 days after the final apheresis (Table 6 ). Blood viscosity was significantly reduced at all shear rates (p<0.01), whereas no significant modification of plasma viscosity was observed. Hematocrit and fibrinogen levels were slightly reduced. Similar changes in blood viscosity (p<0.01 at all shear rates) were seen when viscosity values were adjusted for hematocrit levels in an analysis of covariance. The TK term, an estimate of the rigidity of red blood cells, was reduced from abnormally high toward normal values after one LDL apheresis, although the conventional statistical significance was not attained (2a 0.05 >p <0.10). TK changes were inversely related to baseline TK values (r= -0.994,p<0.001). In other words, patients with relatively higher TK values at baseline showed a decrease, while those with If an adjustment was performed in an analysis of covariance for the variability of TK values before apheresis, then the reduction in TK values after apheresis became highly significant (p<0.001).
Discussion
This study demonstrates an increase in peak blood flow in the legs of about 30%, 3 weeks after six repeat procedures of LDL apheresis. Enhanced peak blood flow during the reactive hyperemia test indicates that more flow is available in conditions of high oxygen demand, such as exercise.9 Arterial blood flow at rest was less affected by LDL apheresis. In the resting condition, the vasoconstrictory influence of sympathetic tone is pronounced. On the other hand, peak blood flow values measured during postischemic reactive hyperemia reflect responses occurring during a period of maximal vasodilation and are, therefore, relatively independent of sympathetic influences. The forearm circulation was apparently less sensitive to LDL apheresis than the leg, possibly because the forearm flow was already maximal at baseline. Peak blood flow in the forearm before apheresis was even higher than peak blood flow in the leg after apheresis ( Table 2 ). This course of treatment, which lasted only 3 months, could not produce a regression of athero-sclerotic lesions significant enough to improve blood flow.
The most likely explanation for the arterial blood flow increase is a reduction of blood viscosity, which has already been shown. 22 One week after a single apheresis, a significant reduction of blood viscosity was seen in the patients; this effect was independent of changes in hematocrit values. In addition to temperature and hematocrit level, other determinants of blood viscosity are thought to be plasma viscosity, the deformational properties of the red blood cells, and the interaction between cells and plasma proteins to form aggregates.23 Plasma viscosity was not modified. The TK term (Table 6 ), an estimate of red blood cell rigidity, was obtained before and after LDL apheresis from the blood viscosity equation. Values for the internal viscosity of the red blood cells have been reported in the past. 24 However, because of difficulties in determining a true value for the hydrodynamic volume of the red blood cells, the term TK (calculated according to the formula in the "Methods") has been proposed for evaluating red blood cell rigidity in different clinical conditions.19 The greater the red blood cell rigidity, the higher the TK term. The finding of a reduction of the TK term, toward values less than 1.00, suggests an improvement of the rheologic properties of erythrocytes after LDL apheresis, which leads to enhanced blood flow. Before adjustment for the variability of baseline values, the reduction of TK was only near to statistical significance; however, it should be remembered that viscosity determinations were performed before and after the last apheresis, when the patients had already undergone five repeat procedures. Conceivably, the change in TK values from the true baseline values (before the first apheresis) could have been even more pronounced. A relation between circulating LDL levels and erythrocyte membrane properties is suggested by the occurrence of abnormally shaped erythrocytes (acanthocytes) in abetalipoproteinemia, a condition characterized by near absence of all circulating LDLs. 25 On the other hand, blood viscosity has already been shown to be abnormally high in human hyperlipoproteinemia26; effective lipidlowering treatment reduces blood viscosity and improves erythrocyte deformability. 27 Plasma exchange has been shown to improve calf arterial blood flow in patients with familial hypercholesterolemia.9 Immediately after plasma exchange, blood and plasma viscosity are significantly reduced.'0 In one patient with familial hypercholesterolemia 6 days after plasma exchange, plasma viscosity (but not blood viscosity) was still lower than that at baseline.10 An improvement of erythrocyte deformability also has been demonstrated."1 In this study, LDL apheresis reduced blood viscosity (but not plasma viscosity), and this probably reflected changes in the rheologic properties of erythrocytes. However, after either plasma exchange or LDL apheresis, it is hard to say to what extent changes in serum cholesterol level, erythrocyte membrane composition, hematocrit values, and blood viscosity are interrelated or to what extent they independently influence blood flow in the leg.
The mechanisms underlying the small but significant reduction in red blood cell counts and hemoglobin levels after repeat LDL apheresis is not known. On the basis of routine blood tests performed during this study, some possibilities can be excluded. Hemodilution can be excluded as a mechanism because no decrease was seen in the other blood measurements (there was even a slight increase in serum sodium and blood urea nitrogen, suggesting some hemoconcentration). Constant bilirubin values do not support the hypothesis of hyperhemolysis. Stable white blood cell and platelet counts make bone marrow toxicity unlikely. We cannot exclude a possible effect of LDL apheresis on serum iron levels. The reduction in red blood cell count is modest and self-limited. After the six procedures for apheresis, half of the patients underwent further procedures for another 18 months, and a further decrease in their hematocrit levels did not occur. The only two female patients with hypermenorrhea who developed overt anemia had their hemoglobin levels completely normalized by iron supplementation.
An alternative mechanism that may explain the increased blood flow to the limbs after apheresis involves the secretion of the endothelium-derived relaxing factor, which regulates the vascular tone through a receptor-dependent pathway.28 In animal models, long-term exposure of the endothelium to a high concentration of LDL inhibits endotheliumdependent relaxation. LDL apheresis would, therefore, be expected to increase the reduction of vascular tone that is dependent on endothelium-derived relaxing factor, and this may contribute to the increase in blood flow. However, if the inhibition of endothelium-dependent relaxation by LDL involves the LDL (apolipoprotein B/E) receptor, then homozygous patients, particularly if receptor negative, should not experience significant changes in blood flow after LDL apheresis. On the other hand, the present data demonstrate improvement in blood flow even in a receptor-negative homozygous patient, without any relation to the receptor status in the other patients.
It is expected that not only arterial blood flow in the leg but also blood flow in the myocardium is increased after LDL apheresis. In addition, cardiac work load might be reduced after apheresis because of lower peripheral resistances, as suggested by the data in Table 5 . Clinical improvement of angina has been reported after plasma exchange and LDL apheresis. 4, 12 Ischemic tissue in several districts, therefore, may benefit from long-term LDL apheresis because of possible regression of flow-reducing atherosclerotic plaques and of improvement of the rheologic properties of blood, both leading to enhanced arterial blood flow.
